MGX- Metagenomi Therapeutics, Inc.

Name: Metagenomi Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Metagenomi Therapeutics, Inc. (MGX) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. MGX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Thomas Brian C.	2.51M	$3.01M	-
Other	Irish Jian	377.5K	$453.0K	-3,737
CFO	Wapnick Pamela	208.5K	$250.2K	-2,884
Other	Wein Matthew	126.5K	$151.8K	-558
Dir	Bjerkholt Eric	21.0K	$25.2K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 5, 2026	Wein Matthew66	See Remarks	Sell	558	$1.30	$724.84	-0.4%	-	-
Jun 5, 2026	Irish Jian64	See Remarks	Sell	3,737	$1.30	$4,854.36	-1.0%	-	-
Jun 5, 2026	Wapnick Pamela69	Chief Financial Officer	Sell	2,884	$1.30	$3,746.32	-1.4%	-	-
Dec 5, 2025	Thomas Brian C.64	Director	Sell	3,830	$1.77	$6,786.38	-0.2%	-9.6%	-
Dec 5, 2025	Wein Matthew66	See Remarks	Sell	199	$1.77	$352.61	-0.2%	-9.6%	-
Dec 5, 2025	Wapnick Pamela69	Chief Financial Officer	Sell	1,576	$1.77	$2,792.51	-0.8%	-9.6%	-
Dec 5, 2025	Irish Jian64	Chief Executive Officer	Sell	1,602	$1.77	$2,838.58	-0.3%	-9.6%	-
Sep 5, 2025	Thomas Brian C.64	Director	Sell	2,701	$1.81	$4,888.81	-0.1%	-6.3%	-
Sep 5, 2025	Wapnick Pamela69	Chief Financial Officer	Sell	1,576	$1.81	$2,852.56	-2.2%	-6.3%	-
Sep 5, 2025	Irish Jian64	Chief Executive Officer	Sell	1,602	$1.81	$2,899.62	-0.5%	-6.3%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC